Asymptomatic intradialytic supraventricular arrhythmias and adverse outcomes in patients on hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 12, 2016, Pages 2210-2217

  Verde, Eduardo ^a   De Prado, Armando Pérez ^b   López Gómez, Juan M ^a   Quiroga, Borja ^a   Goicoechea, Marian ^a   García Prieto, Ana ^a   Torres, Esther ^a   Reque, Javier ^a   Luño, José ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL DE LEÓN   (Spain)

Author keywords

Arrhythmias; Asymptomatic arrhythmias; Atrial fibrillation; Attention; C Reactive Protein; Cause of Death; Chronic dialysis; Confidence Intervals; Diabetes mellitus; Electrocardiography; End stage renal disease; Female; Follow Up Studies; Heart Atria; Heart Conduction System; Hemodialysis; Humans; Hypertension; Incidence; Male; Mortality; Multivariate Analysis; Prevalence; Proportional Hazards Models; Prospective Studies

Indexed keywords

ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; HEMOGLOBIN; MAGNESIUM; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; AGE; AGED; AMBULATORY ELECTROCARDIOGRAPHY; ASYMPTOMATIC DISEASE; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HEART ARRHYTHMIA; HEART ATRIUM; INCIDENCE; METABOLISM; MORTALITY; PROGNOSIS;

ADULT; AGE FACTORS; AGED; ARRHYTHMIAS, CARDIAC; ASYMPTOMATIC DISEASES; C-REACTIVE PROTEIN; CARDIOMEGALY; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 85017835325     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04310416     Document Type: Article

References (39)

1. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM; Board of the EURECA-mWorking Group of ERAEDTA: Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383: 1831-1843, 2014
2. Ritz E, Bommer J: Cardiovascular problems on hemodialysis: Current deficits and potential improvement. Clin J Am Soc Nephrol 4[Suppl 1]: S71-S78, 2009
3. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 63[Suppl]: A7, 2014
4. Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, Tumlin JA; MiD Investigators and Committees: Arrhythmia and sudden death in hemodialysis patients: Protocol and baseline characteristics of the monitoring in dialysis study. Clin J Am Soc Nephrol 11: 721-734, 2016
5. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S: The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22: 349-357, 2011
6. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A: Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46: 897-902, 2005
7. Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM: Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy. Kidney Int 77: 1098-1106, 2010
8. Liao JN, Chao TF, Liu CJ, Wang KL, Chen SJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Chen SA: Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy. Kidney Int 87: 1209-1215, 2015
9. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, Soliman EZ, Astor BC, Coresh J: Chronic kidney disease is associated with the incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 123: 2946-2953, 2011
10. Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, Hsu CY, Kallem RK, Keane MG, Lora CM, Raj D, Soliman EZ, Strauss L, Wolf M, Go AS; CRIC Study: Atrial fibrillation and risk of ESRD in adults with CKD. Clin J Am Soc Nephrol 11: 1189-1196, 2016
11. Severi S, Pogliani D, Fantini G, Fabbrini P, Viganò MR, Galbiati E, Bonforte G, Vincenti A, Stella A, Genovesi S: Alterations of atrial electrophysiology induced by electrolyte variations: Combined computational and P-wave analysis. Europace 12: 842-849, 2010
12. US Renal Data System: Cardiovascular special studies. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda,MD,National Institute of Health,National Institute of Diabetes and Digestive and Kidney Disease. Am J Kidney Dis 47 [Suppl 1]: S173-S184, 2006
13. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM: Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 27: 3816-3822, 2012
14. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 98: 946-952, 1998
15. Vazquez E, Sanchez-Perales C, Garcia-Garcia F, Castellano P, Garcia-Cortes MJ, Liebana A, Lozano C: Atrial fibrillation in incident dialysis patients. Kidney Int 76: 324-330, 2009
16. Genovesi S, Rossi E, Gallieni M, Stella A, Badiali F, Conte F, Pasquali S, Bertoli S, Ondei P, Bonforte G, Pozzi C, Rebora P, Valsecchi MG, Santoro A: Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. Nephrol Dial Transplant 30: 491-498, 2015
17. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O’Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 370: 2467-2477, 2014
18. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL AF Investigators: Cryptogenic stroke and underlying atrial fibrillation. NEngl JMed 370: 2478-2486, 2014
19. Dixon JR Jr.: The International Conference on Harmonization Good Clinical Practice guideline. Qual Assur 6: 65-74, 1998
20. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr., Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr., Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr., Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines. Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to DevelopGuidelines for the Management of PatientsWith Supraventricular Arrhythmias). Circulation 108: 1871-1909, 2003
21. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC Jr., Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO; American College of Cardiology; American Heart Association; American Society of Echocardiography: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108: 1146-1162, 2003
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987
24. Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A: Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121: 1904-1911, 2010
25. Vincenti A, Passini E, Fabbrini P, Luise MC, Severi S, Genovesi S: Recurrent intradialytic paroxysmal atrial fibrillation: Hypotheses on onset mechanisms based on clinical data and computational analysis. Europace 16: 396-404, 2014
26. Brigadeau F, Lacroix D: [Natural history and outcomes of atrial fibrillation]. Rev Prat 63: 193-197, 2013
27. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375, 2001
28. Acar G, Akçay A, Doğan E, Isxik IO, Sökmen A, Sökmen G, Sayarlioğlu H, Köroğlu S, Nacar AB, Tuncer C: The prevalence and predictors of atrial fibrillation in hemodialysis patients. Turk Kardiyol Dern Ars 38: 8-13, 2010
29. Atar I, Konasx D, Açikel S, Külah E, Atar A, Bozbasx H, Gülmez O, Sezer S, Yildirir A, Ozdemir N, Müderrisoğlu H, Ozin B: Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 106: 47-51, 2006
30. De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC: Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res 89: 754-765, 2011
31. Luong C, Thompson DJ, Bennett M, Gin K, Jue J, Barnes ME, Colley P, Tsang TS: Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion. Can J Cardiol 31: 29-35, 2015
32. Akutsu Y, Kaneko K, Kodama Y, Suyama J, Li HL, Hamazaki Y, Tanno K, Gokan T, Kobayashi Y: Association between left and right atrial remodeling with atrial fibrillation recurrence after pulmonary vein catheter ablation in patients with paroxysmal atrial fibrillation: A pilot study. Circ Cardiovasc Imaging 4: 524-531, 2011
33. Korzets A, Ori Y, Herman M: Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant 16: 1090-1091, 2001
34. Krijthe BP, Heeringa J, Kors JA, Hofman A, Franco OH, Witteman JC, Stricker BH: Serum potassium levels and the risk of atrial fibrillation: TheRotterdamStudy. Int J Cardiol 168: 5411-5415, 2013
35. Fujii H, Kim JI, Yoshiya K, Nishi S, Fukagawa M: Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: A prospective follow-up study. Am J Nephrol 34: 126-134, 2011
36. Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, Stella A, Vincenti A: Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant 24: 2529-2536, 2009
37. Chen LY, Sotoodehnia N, Bůžková P, Lopez FL, Yee LM, Heckbert SR, Prineas R, Soliman EZ, Adabag S, Konety S, Folsom AR, Siscovick D, Alonso A: Atrial fibrillation and the risk of sudden cardiac death: The atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med 173: 29-35, 2013
38. Denker S, Lehmann M, Mahmud R, Gilbert C, Akhtar M: Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 53: 508-515, 1984
39. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM: Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 305: 2080-2087, 2011